封面
市場調查報告書
商品編碼
2141394

蛋白質水解物在老年營養領域的市場機會、成長要素、產業趨勢分析及2026-2035年預測

Geriatric Nutrition Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035

出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年,全球用於老年人營養的水解蛋白市場規模將達到 4.44 億美元,年複合成長率為 7.6%,到 ​​2035 年將達到 9.21 億美元。

市場範圍
開始年份 2025
預測期 2026-2035
初始市場規模 4.44億美元
預計金額 9.21億美元
複合年成長率 7.6%

蛋白質水解物是透過酶解、酸處理或鹼處理將蛋白質轉化為較短的肽鍊或遊離氨基酸而製成的。它們在老年營養領域的價值不僅限於提供蛋白質;其獨特的結構使其能夠更快地被吸收,同時減輕消化負擔。這些特性使得水解蛋白在專為老年人開發的營養產品中特別重要,這些老年人面臨胃腸道功能衰退、吸收不良、食慾不振或肌肉萎縮等高風險。隨著人口老化和營養需求日益多樣化,人們對具有更高耐受性和吸收率以及有效補充蛋白質的配方需求不斷成長。因此,製造商正致力於開發基於水解物的營養解決方案,以應對與老齡化相關的生理挑戰。人們對維持營養狀況和肌肉健康的日益關注也推動了臨床和家庭營養護理中對特殊蛋白質來源的需求。

預計到2025年,動物源蛋白水解物市場規模將達到3.15億美元,並在2035年之前以6.8%的複合年成長率成長。在這個市場中,牛奶和酪蛋白水解物是最大的類別,其次是乳清蛋白水解物。動物源蛋白成熟的營養成分和功能特性使其繼續在老年人專用營養配方中得到應用。生產商可以進一步將這些蛋白質來源加工成水解物,以增強其對特定消化和營養需求產品的適用性。

預計到2025年,臨床營養市場規模將達2億美元。醫院營養計畫和腸內營養產品是其主要應用領域,因為胃腸功能衰退和吸收不良可能會增加對水解蛋白製劑的需求。歐洲腸外腸內營養學會(ESPEN)指南將適當的蛋白質補充與老年人的營養護理聯繫起來,進一步推動了旨在提高耐受性和有效吸收的配方的發展。因此,能夠應對與老齡化和消化功能衰退相關的飲食挑戰的專業營養解決方案的需求,進一步推動了對臨床營養產品的需求。

預計到2025年,北美老年營養用水解蛋白市場規模將達到1.46億美元,並在2035年之前以6.6%的複合年成長率成長。美國是該地區領先的市場,這得益於醫院營養支持團隊、完善的家庭經腸營養系統以及消費者營養補充劑的廣泛普及。這些多元化的分銷管道使製造商能夠觸及機構和居家照護環境中的老年消費者。加拿大在機構臨床營養領域也產生了額外的需求,但由於其在該地區相對較高的市場滲透率,預計其成長速度將比新興市場更為溫和。

目錄

第1章:調查方法

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
    • 供應商情況
    • 利潤率
    • 每個階段增加的價值
    • 影響價值鏈的因素
    • 中斷
  • 影響產業的因素
    • 促進因素
    • 產業潛在風險與挑戰
    • 市場機遇
  • 成長潛力分析
  • 監理情勢
  • 波特的分析
  • PESTLE分析
  • 價格趨勢
    • 按地區
    • 依產品
  • 未來市場趨勢
  • 技術與創新展望
    • 最新科技趨勢
    • 新興技術
  • 專利趨勢
  • 貿易統計資料(註:貿易統計僅涵蓋主要國家)
    • 主要進口國
    • 主要出口國
  • 永續性和環境方面
    • 永續計劃
    • 減少廢棄物策略
    • 生產中的能源效率
    • 具有環保意識的舉措
  • 考慮碳足跡

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估算與預測:依原料分類,2022-2035年

  • 動物源性
    • 乳蛋白質水解物(酪蛋白、乳清蛋白)
    • 蛋清蛋白水解物
    • 肉類蛋白水解物
    • 魚蛋白水解物
  • 植物來源
    • 大豆蛋白水解物
    • 豌豆蛋白水解物
    • 米蛋白質水解物
    • 其他植物來源成分(例如,小麥、玉米)

第6章 市場估計與預測:依通路分類,2022-2035年

  • 醫院藥房
  • 零售藥房
  • 網路商店
  • 專賣店

第7章 市場估計與預測:依應用領域分類,2022-2035年

  • 臨床營養
    • 醫院營養
    • 腸內營養製劑
  • 功能性食品和飲料
    • 能量飲料
    • 營養強化食品
  • 營養補充品
    • 膠囊
    • 藥片
    • 小袋
  • 其他

第8章 市場估計與預測:依地區分類,2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 其他中東和非洲國家

第9章:公司簡介

  • Arla Foods Ingredients
  • Mead Johnson Nutrition
  • Merck KGaA
  • Fonterra Co-operative Group
  • Agropur Cooperative
  • Milk Specialties Global
  • Tatua Co-operative Dairy Company
  • Royal FrieslandCampina NV
  • Hilmar Cheese Company
  • Kerry Group
  • DuPont(Danisco)
  • Nestle Health Science
  • Rousselot
  • Gelita AG
  • Evonik Industries
簡介目錄
Product Code: 15311

The Global Geriatric Nutrition Protein Hydrolysates Market was valued at USD 444 million in 2025 and is estimated to grow at a CAGR of 7.6% to reach USD 921 million by 2035.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$444 Million
Forecast Value$921 Million
CAGR7.6%

Protein hydrolysates are produced by converting proteins into shorter peptide chains and free amino acids through enzymatic, acid, or alkaline processing. Their value in geriatric nutrition extends beyond delivering protein because their structure can support faster absorption while reducing digestive demands. These characteristics make hydrolyzed protein particularly relevant to nutritional products developed for older adults experiencing gastrointestinal impairment, malabsorption, reduced appetite, or an elevated risk of muscle loss. As aging populations increase and nutritional requirements become more specialized, demand is shifting toward formulations that can provide effective protein support with improved tolerance and absorption. Manufacturers are consequently focusing on hydrolysate-based nutritional solutions that address the physiological challenges associated with aging. The growing emphasis on maintaining nutritional status and supporting muscle health is also creating opportunities for specialized protein ingredients across clinical and home-based nutrition settings.

Animal-based protein hydrolysates segment accounted for USD 315 million in 2025 and is forecast to grow at a CAGR of 6.8% through 2035. Milk and casein hydrolysates represent the largest category within this segment, while whey protein hydrolysates rank next. The established nutritional profiles and functional characteristics of animal-derived proteins continue to support their use in specialized geriatric nutrition formulations. Manufacturers can further process these protein sources into hydrolysates to improve their suitability for products designed around specific digestive and nutritional requirements.

Clinical nutrition segment held USD 200 million in 2025. Hospital nutrition programs and tube-feeding products represent the dominant areas of use, as gastrointestinal impairment and malabsorption can increase the need for hydrolyzed protein formulations. ESPEN guidance connects adequate protein support with nutritional care for older adults, providing additional support for formulas designed to promote tolerance and efficient absorption. Demand for clinical nutrition products is therefore being reinforced by the need for specialized nutritional solutions that can address the dietary challenges associated with aging and compromised digestive function.

North America Geriatric Nutrition Protein Hydrolysates Market captured USD 146 million in 2025 and is forecast to grow at a CAGR of 6.6% through 2035. The United States serves as the region's primary market, supported by hospital-based nutrition support teams, established homecare enteral nutrition systems, and broad access to direct-to-consumer supplements. These multiple distribution channels allow manufacturers to reach older consumers across institutional and home-based care environments. Canada contributes additional demand from institutional clinical nutrition, although the region's relatively high market penetration is expected to moderate its growth rate compared with less-developed markets.

Major companies participating in the global geriatric nutrition protein hydrolysates market include Fonterra, Nestle Health Science, Arla Foods Ingredients, Royal FrieslandCampina, and Kerry Group. Companies in the global geriatric nutrition protein hydrolysates market are strengthening their market foothold through product innovation, portfolio expansion, clinical nutrition partnerships, and improvements in formulation technology. Leading participants are developing hydrolysates with targeted peptide profiles to support digestibility, absorption, and nutritional tolerance among older consumers. Companies are also expanding their protein portfolios across milk, casein, and whey sources to address diverse formulation requirements. Partnerships with healthcare providers, nutrition specialists, and institutional care channels can help manufacturers expand product adoption and strengthen market access. Investments in research and development enable suppliers to improve formulation performance while responding to evolving geriatric nutrition needs. Companies are also increasing distribution through homecare and consumer channels to reach broader customer groups. By combining specialized product development, quality improvements, expanded distribution networks, and stronger relationships across clinical nutrition channels, market participants are positioning themselves to capture growing demand for protein hydrolysate solutions in geriatric care.

Table of Contents

Chapter 1. Methodology

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2. Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Source
    • 2.2.3 Distribution Channel
    • 2.2.4 Application
  • 2.3 TAM Analysis, 2026-2035
  • 2.4 CXO perspectives: Strategic imperatives
    • 2.4.1 Executive decision points
    • 2.4.2 Critical success factors
  • 2.5 Future Outlook and Strategic Recommendations

Chapter 3. Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier Landscape
    • 3.1.2 Profit Margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
    • 3.1.5 Disruptions
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Industry pitfalls and challenges
    • 3.2.3 Market opportunities
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East & Africa
  • 3.5 Porter’s analysis
  • 3.6 PESTEL analysis
  • 3.7 Price trends
    • 3.7.1 By region
    • 3.7.2 By product
  • 3.8 Future market trends
  • 3.9 Technology and Innovation landscape
    • 3.9.1 Current technological trends
    • 3.9.2 Emerging technologies
  • 3.10 Patent Landscape
  • 3.11 Trade statistics (Note: the trade statistics will be provided for key countries only)
    • 3.11.1 Major importing countries
    • 3.11.2 Major exporting countries
  • 3.12 Sustainability and Environmental Aspects
    • 3.12.1 Sustainable Practices
    • 3.12.2 Waste Reduction Strategies
    • 3.12.3 Energy Efficiency in Production
    • 3.12.4 Eco-friendly Initiatives
  • 3.13 Carbon Footprint Considerations

Chapter 4. Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 LATAM
      • 4.2.1.5 MEA
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New Product Launches
    • 4.6.4 Expansion Plans

Chapter 5. Market Estimates and Forecast, By Source, 2022 - 2035 (USD Million, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Animal-based
    • 5.2.1 Milk protein hydrolysates (casein, whey)
    • 5.2.2 Egg protein hydrolysates
    • 5.2.3 Meat protein hydrolysates
    • 5.2.4 Fish protein hydrolysates
  • 5.3 Plant-based
    • 5.3.1 Soy protein hydrolysates
    • 5.3.2 Pea protein hydrolysates
    • 5.3.3 Rice protein hydrolysates
    • 5.3.4 Other plant sources (e.g., wheat, corn)

Chapter 6. Market Estimates and Forecast, By Distribution Channel, 2022 - 2035 (USD Million, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Hospital pharmacies
  • 6.3 Retail pharmacies
  • 6.4 Online stores
  • 6.5 Specialty stores

Chapter 7. Market Estimates and Forecast, By Application, 2022 - 2035 (USD Million, Kilo Tons)

  • 7.1 Key trends
  • 7.2 Clinical nutrition
    • 7.2.1 Hospital-based nutrition
    • 7.2.2 Tube feeding formulations
  • 7.3 Functional foods & beverages
    • 7.3.1 Nutritional drinks
    • 7.3.2 Fortified foods
  • 7.4 Dietary supplements
    • 7.4.1 Capsules
    • 7.4.2 Tablets
    • 7.4.3 Sachets
  • 7.5 Others

Chapter 8. Market Estimates and Forecast, By Region, 2022 - 2035 (USD Million, Kilo Tons)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 South Africa
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East & Africa

Chapter 9. Company Profiles

  • 9.1 Arla Foods Ingredients
  • 9.2 Mead Johnson Nutrition
  • 9.3 Merck KGaA
  • 9.4 Fonterra Co-operative Group
  • 9.5 Agropur Cooperative
  • 9.6 Milk Specialties Global
  • 9.7 Tatua Co-operative Dairy Company
  • 9.8 Royal FrieslandCampina N.V.
  • 9.9 Hilmar Cheese Company
  • 9.10 Kerry Group
  • 9.11 DuPont (Danisco)
  • 9.12 Nestle Health Science
  • 9.13 Rousselot
  • 9.14 Gelita AG
  • 9.15 Evonik Industries